Globe Life (NYSE:GL - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 14.250-14.650 for the period, compared to the consensus earnings per share estimate of 13.627. The company issued revenue guidance of -.
Globe Life Trading Up 2.8%
GL stock traded up $3.70 on Friday, hitting $135.22. 1,363,169 shares of the company were exchanged, compared to its average volume of 647,259. Globe Life has a twelve month low of $86.10 and a twelve month high of $138.41. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.07 and a quick ratio of 0.07. The business's fifty day moving average is $121.24 and its two-hundred day moving average is $121.87. The stock has a market capitalization of $11.16 billion, a price-to-earnings ratio of 10.81 and a beta of 0.56.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, beating analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.55%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the prior year, the firm posted $2.97 EPS. The firm's revenue was up 2.9% compared to the same quarter last year. As a group, research analysts forecast that Globe Life will post 13.87 earnings per share for the current year.
Analysts Set New Price Targets
GL has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their price objective on shares of Globe Life from $144.00 to $150.00 and gave the company an "overweight" rating in a research report on Friday. Wall Street Zen raised shares of Globe Life from a "hold" rating to a "buy" rating in a research report on Friday, May 16th. JPMorgan Chase & Co. boosted their price objective on shares of Globe Life from $145.00 to $160.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Piper Sandler lowered their price objective on shares of Globe Life from $152.00 to $147.00 and set an "overweight" rating on the stock in a research report on Friday, May 2nd. Finally, Truist Financial began coverage on shares of Globe Life in a research note on Tuesday, July 15th. They issued a "buy" rating and a $150.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $145.09.
Read Our Latest Report on GL
Insider Buying and Selling at Globe Life
In related news, CEO Frank M. Svoboda sold 6,019 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $122.51, for a total transaction of $737,387.69. Following the transaction, the chief executive officer directly owned 31,298 shares of the company's stock, valued at approximately $3,834,317.98. This trade represents a 16.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.51% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. increased its position in Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock valued at $74,161,000 after acquiring an additional 58,163 shares during the last quarter. NewEdge Advisors LLC increased its position in Globe Life by 368.1% in the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock worth $897,000 after buying an additional 5,352 shares in the last quarter. Empowered Funds LLC purchased a new stake in Globe Life in the first quarter worth about $428,000. Acadian Asset Management LLC purchased a new stake in Globe Life in the first quarter worth about $322,000. Finally, Focus Partners Wealth increased its position in Globe Life by 8.3% in the first quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock worth $1,127,000 after buying an additional 656 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.
Globe Life Company Profile
(
Get Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
